Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 71,500 | 69,120 | 64,123 | 60,083 | 47,347 |
| Operating Income | -71,500 | -69,120 | -64,123 | -60,083 | -47,347 |
| Interest Expense | 3,990 | 1,634 | 1,580 | 1,617 | 1,142 |
| Other Income | 719 | 121 | 21 | -289 | -158 |
| Pre-tax Income | -74,771 | -70,633 | -65,682 | -61,989 | -48,647 |
| Income Tax | 243 | N/A | 88 | 145 | -394 |
| Net Income Continuous | -75,014 | -70,633 | -65,770 | -62,134 | -48,253 |
| Net Income | $-75,014 | $-70,633 | $-65,770 | $-62,134 | $-48,253 |
| EPS Basic Total Ops | -1.08 | -1.04 | -0.99 | -0.98 | -0.82 |
| EPS Basic Continuous Ops | -1.08 | -1.04 | -0.99 | -0.98 | -0.81 |
| EPS Diluted Total Ops | -1.08 | -1.04 | -0.99 | -0.98 | -0.82 |
| EPS Diluted Continuous Ops | -1.08 | -1.04 | -0.99 | -0.98 | -0.81 |
| EBITDA(a) | $-70,654 | $-68,571 | $-63,594 | $-59,485 | $-46,999 |